High frequency of resistance to the drugs isoniazid and rifampicin among tuberculosis cases in the City of Cabo de Santo Agostinho, an urban area in Northeastern Brazil

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 41, Issue 1, 2008, Pages 11-16

  Baliza, Marcilio ^a,f   Bach, Artur Henrique ^a   De Queiroz, Gabriel Lobo ^a   Melo, Inês Cardoso ^b   Carneiro, Maria Madileuza ^c   De Albuquerque, Maria De Fátima Pessoa Militão ^a   Suffys, Philip ^a   Rodrigues, Laura ^d   Ximenes, Ricardo ^e   Lucena Silva, Norma ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Secretaria de Saúde do Cabo de Santo Agostinho   (United States)

^c Secretaria de Saude do Estado de Pernambuco   (Brazil)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^f UNIVERSIDADE FEDERAL DO RECÔNCAVO DA BAHIA   (Brazil)

Author keywords

Drug resistance; Multidrug resistance; Risk factors; Tuberculosis

Indexed keywords

4 NITROBENZOIC ACID; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLOSCOPY; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BRAZIL; DIAGNOSTIC PROCEDURE; DISEASE CONTROL; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM; PATIENT COMPLIANCE; PREVALENCE; RISK FACTOR; STATISTICAL ANALYSIS; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; BRAZIL; EPIDEMIOLOGIC METHODS; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HUMANS; ISONIAZID; MALE; MIDDLE AGED; RIFAMPIN; TUBERCULOSIS, PULMONARY; URBAN POPULATION;

EID: 41549101119     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822008000100003     Document Type: Article

References (25)

1. Albuquerque MFPM, Ximenes RAA, Lucena-Silva N, Souza WV, Dantas AT, Dantas OMS, Rodrigues LC. Factors associated with treatment failure, dropout, and death in a cohort of tuberculosis patients in Recife, Pernambuco State, Brazil. Caderno de Saúde Pública 23: 105-114, 2007.
2. Barroso EC, Rodrigues JLN, Pinheiro VGF, Campelo CL. Prevalência da tuberculose multirresistente no Estado do Ceará, 1990-1999. Jornal de Pneumologia 27: 310-314, 2001.
3. Cox HS, Orozco JD, Male R, Ruesch-Gerdes S, Falzon D, Small I, Doshetov D, Kebede Y, Aziz M. Multidrug-resistant tuberculosis in Central Asia. Emerging Infectious Diseases 10: 865-872, 2005.
4. Dewan P, Sosnovskaja A, Thomsen V, Cicenaite J, Laserson K, Johansen I, Davidaviciene E, Wells C. High prevalence of drug-resistant tuberculosis, Republic of Lithuania, 2002. The International Journal of Tuberculosis and Lung Disease 9:170-174, 2005.
5. Faustini A, Hall AJ, Perucci CA. Risk factors for multi-drug resistant tuberculosis in Europe: a systematic review. Thorax 61:158-163, 2006.
6. Granich RM, Oh P, Lewis B, Porco TC, Flood J. Multi-drug resistance among persons with tuberculosis in California, 1994-2003. Journal of American Medical Association 293: 2732-2739, 2005.
7. Hsueh PR, Liu YC, So J, Liu CY, Yang PC, Luh KT. Mycobacterium tuberculosis in Taiwan. Journal of Infection 52:77-85, 2006.
8. Kart L, Altin R, Tor M, Gulmez I, Oymak SF, Atmaca HM, Erdem F. Anti-tuberculosis drug resistance patterns in two regions of turkey: a retrospective analysis. Annals of Clinical Microbiology and Antimicrobials 16: 1-6, 2002.
9. Kritski AL, Ruffino-Netto A. Health sector reform in Brazil: impact on tuberculosis control. The International Journal of Tuberculosis and Lung Disease 4: 622-626, 2000.
10. Min SM, Kelly P, Byrne C, Clancy L. Antibiotic resistant tuberculosis and bovine tuberculosis in an Irish hospital population (1991 to 2001). Irish Medical Journal 98: 38-40, 2005.
11. Ministério da Saúde do Brasil. Tuberculose-guia de vigilância epidemiológica/elaborado pelo Comitê Técnico-científico de Assessoramento à Tuberculose e Comitê Assessor para Co-infecção HIV-Tuberculose. Ministério da Saúde/Fundação Nacional da Saúde, Brasília, 2002.
12. Moreira CA, Hernandez HL, Arias NL, Castano MC, Ferro BE, Jaramillos E. Initial drug resistance as a threat for tuberculosis control: the case of Buenaventura, Colombia. Biomedica 1: 73-79, 2004.
13. Natal S, Valente JG, Sánchez AR, Penna MLF. Resistência a isoniazida e rifampicina e história de tratamento anterior para tuberculose. Caderno de Saúde Pública 19: 1277-1281, 2003.
14. Nunes EA, De Capitani EM, Coelho E, Joaquim OA, Figueiredo IRO, Cossa AM, Panunto AC, Carvalho-Ramos M. Patterns of anti-tuberculosis drug resistance among HIV-infected patients in Maputo, Mozambique, 2002-2003. The International Journal of Tuberculosis and Lung Disease 9: 494-500, 2005.
15. Ormerod LP. Multi-drug resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. British Medical Bulletin 73-74: 17-24, 2005.
16. Pablo-Méndez A, Gowda DK, Frieden TR. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework. Bulletin of the World Health Organization 80: 489-500, 2002.
17. Paramasivan CN, Venkataraman P. Drug resistance in tuberculosis in India. Indian Journal of Medical Research 120: 377-386, 2004.
18. Pozniak A. Multidrug-resistant tuberculosis and HIV infection. Annals New York Academy of Science 953: 192-198, 2001.
19. Raviglione MC, Gupta R, Dye CM, Espinal MA. The burden of drug-resistant tuberculosis and mechanisms for its control. Annals New York Academy of Science 953: 88-97, 2001.
20. Surucuoglu S, Ozkutuk N, Celik P Gazi H, Dinc G, Kurutepe S, Koroglu G, Havlucu Y, Tuncay G. Drug-resistant pulmonary tuberculosis in western Turkey: prevalence, clinical characteristics and treatment outcome. Annals Saudi Medicine 25: 313-318, 2005.
21. Telles MA, Ferrazoli L, Waldman EA, Giampaglia CM, Martins MC, Ueki SY, Chimara E, Silva CA, Cruz V, Waldman CC, Heyn I, Hirono IU, Riley LW. A population-based study of drug resistance and transmission of tuberculosis in an urban community. The International Journal of Tuberculosis and Lung Disease 9: 970-976, 2005.
22. Vanacore P, Koehler B, Zacchini F, Bassetti D, Antonucci G, Hipólito G, Girardi E, GISTA-SIMIT Study Group. Drug-resistant tuberculosis in HIV-infected persons: Italy 1999-2000. Infection 32: 328-332, 2004.
23. World Health Organization. Anti-TB drug resistance in the world. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. WHO, Geneva, 1997.
24. World Health Organization. Anti-TB drug resistance in the world. Prevalence of drug resistance. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. WHO, Geneva, 2004.
25. Zaman K, Rahim Z, Yunus M, Arifeen SE, Baqui AH, Sack DA, Hossain S, Banu S, Islam MA, Ahmed J, Breiman RF, Black RE. Drug resistance of Mycobacterium tuberculosis in selected urban and rural areas in Bangladesh. Scandinavian Journal of Infectious Diseases 37: 21-26, 2005.